This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiological aspects. Ophthalmol Clin North Am 2005;18: 75–84.SinghADBergmanLSeregardSUveal melanoma: epidemiological aspectsOphthalmol Clin North Am200518758410.1016/j.ohc.2004.07.002Search in Google Scholar
Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment and survival. Ophthalmology. 2011; 118: 1881–5.SinghADTurellMETophamAKUveal melanoma: trends in incidence, treatment and survivalOphthalmology20111181881510.1016/j.ophtha.2011.01.040Search in Google Scholar
Virgili D, Gatta G, Ciccolallo L, Capoccacia R, Biggeri A. Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114: 2309–15.VirgiliDGattaGCiccolalloLCapoccaciaRBiggeriAIncidence of uveal melanoma in EuropeOphthalmology200711423091510.1016/j.ophtha.2007.01.032Search in Google Scholar
Cancer incidence in Slovenia 1983–2009. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia, 1987–2012.Cancer incidence in Slovenia 1983-2009. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia19872012Search in Google Scholar
Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report No1. Arch Ophthalmol 1990; 108: 1268–73.Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report No1Arch Ophthalmol199010812687310.1001/archopht.1990.01070110084030Search in Google Scholar
Shields JA, Shields CL. Current management of posterior uveal melanoma. Mayo Clin Proc 1993; 68: 1196–200.ShieldsJAShieldsCLCurrent management of posterior uveal melanomaMayo Clin Proc199368119620010.1016/S0025-6196(12)60072-XSearch in Google Scholar
Shields JA, Shields CL, De Potter P, Singh AD. Diagnosis and treatment of uveal melanoma. Semin Oncol 1996; 23: 763–7.ShieldsJAShieldsCLDe PotterPSinghADDiagnosis and treatment of uveal melanomaSemin Oncol1996237637Search in Google Scholar
Hungerford JL. Management of ocular melanoma. British Medical Bulletin 1995; 51: 694–716.HungerfordJLManagement of ocular melanomaBritish Medical Bulletin19955169471610.1093/oxfordjournals.bmb.a072987Search in Google Scholar
Albert DM. The ocular melanoma story, Edward Jackson memorial lecture: Part II. Am J Ophthalmol 1997; 123: 729–41.AlbertDMThe ocular melanoma story, Edward Jackson memorial lecture: Part IIAm J Ophthalmol19971237294110.1016/S0002-9394(14)71119-5Search in Google Scholar
Kertes PJ, Johnson JC, Peyman GA. Internal resection of posterior uveal melanomas. B J Ophthalmol 1998; 82: 1147–53.KertesPJJohnsonJCPeymanGAInternal resection of posterior uveal melanomasB J Ophthalmol19988211475310.1136/bjo.82.10.1147Search in Google Scholar
Packer S, Stoller S, Lesser ML, Mandel FS, Finger PT. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992; 99: 767–73.PackerSStollerSLesserMLMandelFSFingerPTLong-term results of iodine 125 irradiation of uveal melanomaOphthalmology1992997677310.1016/S0161-6420(92)31899-8Search in Google Scholar
Vrabec TR, Augsburger JJ, Gamel JW, Brady LW, Hernandez C, Woodleigh R. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991; 89: 984–8.VrabecTRAugsburgerJJGamelJWBradyLWHernandezCWoodleighRImpact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapyOphthalmology199189984810.1016/S0161-6420(91)32193-6Search in Google Scholar
Augsburger JJ, Mullen D, Kleineidam M. Planned combined I 125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanoma. Ophthalmic Surgery 1993; 24: 76–81.AugsburgerJJMullenDKleineidamMPlanned combined I 125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanomaOphthalmic Surgery199324768110.3928/1542-8877-19930201-03Search in Google Scholar
Papageorgiou KI, Cohen VML, Bunce C, Kinsella M, Hungerford JL. Predicting local control of choroidal melanomas following 106 Ru plaque brachy-therapy. Br J Ophthalmol 2011; 95: 166–70.PapageorgiouKICohenVMLBunceCKinsellaMHungerfordJLPredicting local control of choroidal melanomas following 106 Ru plaque brachy-therapyBr J Ophthalmol2011951667010.1136/bjo.2009.176198Search in Google Scholar
Bercher L, Zografos L, Egger E, Chamot L, Uffer S, Gaillaud C. [Treatment of exterior extension of choroid melanomas by accelerated proton beams]. [French]. Klin Monbl Augenheilkd 1992; 200: 440–3.BercherLZografosLEggerEChamotLUfferSGaillaudC[Treatment of exterior extension of choroid melanomas by accelerated proton beams]. [French]Klin Monbl Augenheilkd1992200440310.1055/s-2008-1045787Search in Google Scholar
Zografos L, Bercher L, Egger E. [Treatment of eye tumors by accelerated proton beams. 7 years experience]. [French]. Klin Monbl Augenheilkd 1992; 200: 431–5.ZografosLBercherLEggerE[Treatment of eye tumors by accelerated proton beams. 7 years experience]. [French]Klin Monbl Augenheilkd1992200431510.1055/s-2008-1045785Search in Google Scholar
Saornil MJ, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs. enucleated uveal melanomas. Arch Ophthalmol 1992; 110: 1112–8.SaornilMJEganKMGragoudasESSeddonJMWalshSMAlbertDMHistopathology of proton beam-irradiated vs. enucleated uveal melanomasArch Ophthalmol19921101112810.1001/archopht.1992.01080200092031Search in Google Scholar
Char DH, Castro JR, Kroll SM, Irvine AR, Quivery JM, Stone RD. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990; 108: 209–14.CharDHCastroJRKrollSMIrvineARQuiveryJMStoneRDFive-year follow-up of helium ion therapy for uveal melanomaArch Ophthalmol19901082091410.1001/archopht.1990.01070040061031Search in Google Scholar
Char DH, Quivery JM, Castro JR, Kroll SK, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. Ophthalmology 1993; 100: 1547–54.CharDHQuiveryJMCastroJRKrollSKPhillipsTHelium ions versus iodine 125 brachytherapy in the management of uveal melanomaOphthalmology199310015475410.1016/S0161-6420(93)31446-6Search in Google Scholar
Char CH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal mela-noma. Am J Ophthalmol 1998; 25: 81–9.CharCHKrollSMCastroJTen-year follow-up of helium ion therapy for uveal mela-nomaAm J Ophthalmol19982581910.1016/S0002-9394(99)80238-4Search in Google Scholar
Damato BE, Paul J, Foulds WS. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996; 80: 102–8.DamatoBEPaulJFouldsWSRisk factors for residual and recurrent uveal melanoma after trans-scleral local resectionBr J Ophthalmol199680102810.1136/bjo.80.2.1025053998814738Search in Google Scholar
Char DH. Clinical ocular oncology. 2nd edition. Philadelphia: Lippincott-Raven Publishers; 1997. p. 114–60.CharDHClinical ocular oncology2nd editionPhiladelphiaLippincott-Raven Publishers199711460Search in Google Scholar
Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995; 113: 315–21.OosterhuisJAJournee-de KorverHGKakebeeke-KemmeHMBleekerJCTranspupillary thermotherapy in choroidal melanomasArch Ophthalmol19951133152110.1001/archopht.1995.011000300710247887845Search in Google Scholar
Lommatzsch PK. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years experience. Br J Ophthalmol 1986; 70: 844–51.LommatzschPKResults after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years experienceBr J Ophthalmol1986708445110.1136/bjo.70.11.84410408403790487Search in Google Scholar
Lommatzsch PK. Radiotherapie der intraokularen Tumoren, insbesondere bei Aderhautmelanom. [Experience in treatment of retinoblastoma in the German Democratic Republic]. [German]. Klin Monbl Augenheilkd 1979; 174: 948–58.LommatzschPKRadiotherapie der intraokularen Tumoren, insbesondere bei Aderhautmelanom. [Experience in treatment of retinoblastoma in the German Democratic Republic]. [German]Klin Monbl Augenheilkd197917494858Search in Google Scholar
Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/ Rh-106 brachytherapy for posterior uveal melanoma. Graefe’s Arch Clin Exp Ophthalmol 2000; 238: 129–37.LommatzschPKWerschnikCSchusterELong-term follow-up of Ru-106/ Rh-106 brachytherapy for posterior uveal melanomaGraefe’s Arch Clin Exp Ophthalmol20002381293710.1007/PL00007880Search in Google Scholar
Jančar B. [Choroidal melanoma]. [Slovenian]. Zdrav Vestn 1992; 61: 439–41.JančarB[Choroidal melanoma]. [Slovenian]Zdrav Vestn19926143941Search in Google Scholar
Novak-Andrejčič K, Logar P, Brovet-Zupančič I, Jančar B. [Treatment of choroidal melanoma with Ru-106 brachytherapy - 14-year experience]. [Slovenian]. Zdrav Vestn 2002; 71(Suppl II): 67–70.Novak-AndrejčičKLogarPBrovet-ZupančičIJančarB[Treatment of choroidal melanoma with Ru-106 brachytherapy - 14-year experience]. [Slovenian]Zdrav Vestn200271(Suppl II)6770Search in Google Scholar
Solivetti FM, Elia F, Santaguida MG, Guerrisi A, Visca P, Cercato MC, et al. The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours. Radiol Oncol 2014; 48: 29–34.SolivettiFMEliaFSantaguidaMGGuerrisiAViscaPCercatoMCThe role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumoursRadiol Oncol201448293410.2478/raon-2013-0084390884424587776Search in Google Scholar
The COMS randomized trial of Iodine125 brachytherapy for choroidal melanoma. COMS report No. 28. Arch Ophthalmol 2006; 124: 1684–93.The COMS randomized trial of Iodine125 brachytherapy for choroidal melanoma. COMS report No. 28Arch Ophthalmol200612416849310.1001/archopht.124.12.168417159027Search in Google Scholar
Guthoff R, Frischmuth J, Jensen OA. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation]. [German]. Klin Monbl Augenheilkd 1992; 200: 257–61.GuthoffRFrischmuthJJensenOA[Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation]. [German]Klin Monbl Augenheilkd19922002576110.1055/s-2008-10457481614086Search in Google Scholar
Rouberol F, Roy P, Kodjikian L, Gerard JP, Jean-Louis B. Survival, anatomic and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy. Am J Ophthalmol 2004; 137: 893–900.RouberolFRoyPKodjikianLGerardJPJean-Louis B. Survival, anatomic and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapyAm J Ophthalmol200413789390010.1016/j.ajo.2003.12.03215126155Search in Google Scholar
Damato BE, Heimann H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol 2014; 132: 605–13.DamatoBEHeimannHKaliraiHCouplandSEAge, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survivalJAMA Ophthalmol20141326051310.1001/jamaophthalmol.2014.7724626610Search in Google Scholar
Damato B, Coupland SE. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond) 2009; 23: 2152–60.DamatoBCouplandSEA reappraisal of the significance of largest basal diameter of posterior uveal melanomaEye (Lond)20092321526010.1038/eye.2009.23519876071Search in Google Scholar
Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Kivela T. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol 2013: 31: 2825–31.KujalaEDamatoBCouplandSEDesjardinsLBechrakisNEKivelaTStaging of ciliary body and choroidal melanomas based on anatomic extentJ Clin Oncol20133128253110.1200/JCO.2012.45.277123816968Search in Google Scholar
Shields CL, Furuta M, Thangappan A, Nagori S. Metastasis of uveal melanoma milimeter by milimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 898–98.ShieldsCLFurutaMThangappanANagoriSMetastasis of uveal melanoma milimeter by milimeter in 8033 consecutive eyesArch Ophthalmol20091278989810.1001/archophthalmol.2009.20819667335Search in Google Scholar
Damato B. Progress in the management of patients with uveal melanoma. Eye (Lond) 2012; 26: 1157–72.DamatoBProgress in the management of patients with uveal melanomaEye (Lond)20122611577210.1038/eye.2012.126Search in Google Scholar
Paul EU, Paunell BL, Braker M. Prognostic factors in malignant melanoma of the choroid and ciliary body. Int J Ophthalmol Clin 1962; 2: 387–402.PaulEUPaunellBLBrakerMPrognostic factors in malignant melanoma of the choroid and ciliary bodyInt J Ophthalmol Clin19622:38740210.1097/00004397-196206000-00007Search in Google Scholar
Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R. Prognostic implications of monosomy in uveal melanoma. Lancet 1996; 347: 1222–5.PrescherGBornfeldNHircheHHorsthemkeBJöckelKHBecherRPrognostic implications of monosomy in uveal melanomaLancet19963471222510.1016/S0140-6736(96)90736-9Search in Google Scholar
Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 2007; 13: 2923–7.OnkenMDWorleyLAPersonECharDHBowcockAMHarbourJWLoss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanomaClin Cancer Res2007132923710.1158/1078-0432.CCR-06-2383Search in Google Scholar
Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR. Identification of chromosomes 3, 6, and 8 aberrrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 2000; 122: 13–7.TschentscherFPrescherGZeschnigkMHorsthemkeBLohmannDRIdentification of chromosomes 3, 6, and 8 aberrrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridizationCancer Genet Cytogenet200012213710.1016/S0165-4608(00)00266-1Search in Google Scholar
Mossbock G, Rauscher T, Winkler P, Kapp KS, Langman G. Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106. Strahlenther Onkol 2007; 10: 571–5.MossbockGRauscherTWinklerPKappKSLangmanGImpact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106Strahlenther Onkol200710571510.1007/s00066-007-1734-xSearch in Google Scholar
Zimmerman L, McLean IW, Foster WD. Does enucleation of the eye containing malignant a melanoma prevent or accelerate the dissemination of malignant cells. Br J Ophthalmol 1978; 62: 420–5.ZimmermanLMcLeanIWFosterWDDoes enucleation of the eye containing malignant a melanoma prevent or accelerate the dissemination of malignant cellsBr J Ophthalmol197862420510.1136/bjo.62.6.420Search in Google Scholar
Zimmerman L, McLean IW. An evaluation of the enucleation in the management of uveal melanoma. Am J Ophthalmol 1979; 87: 741–60.ZimmermanLMcLeanIWAn evaluation of the enucleation in the management of uveal melanomaAm J Ophthalmol1979877416010.1016/0002-9394(79)90348-9Search in Google Scholar
Seddon JM, Gragoudas ES, Egan KM, Polivogianis L. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97: 769–77.SeddonJMGragoudasESEganKMPolivogianisLRelative survival rates after alternative therapies for uveal melanomaOphthalmology1990977697710.1016/S0161-6420(90)32512-5Search in Google Scholar
Westphal JR, Hullenaar RV, Geurts-Moespot A, Sweep FC, Verheijen JH, Bussemakers MM. Angiostatin generation by human tumor cell lines. Int J Cancer 2000; 86: 760–7.WestphalJRHullenaarRVGeurts-MoespotASweepFCVerheijenJHBussemakersMMAngiostatin generation by human tumor cell linesInt J Cancer200086760710.1002/(SICI)1097-0215(20000615)86:6<760::AID-IJC2>3.0.CO;2-4Search in Google Scholar
Apte RS, Niederkorn JY, Mayhew E, Alizadeh H. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol 2001; 119: 1805–9.ApteRSNiederkornJYMayhewEAlizadehHAngiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastasesArch Ophthalmol20011191805910.1001/archopht.119.12.1805Search in Google Scholar
Grossniklaus HE. Progression of ocular melanoma metastasis to the liver JAMA Ophthalmol 2013; 131: 462–9.GrossniklausHEProgression of ocular melanoma metastasis to the liverJAMA Ophthalmol2013131462910.1001/jamaophthalmol.2013.2547Search in Google Scholar
Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 2003; 169: 1122–33.KauffmanECRobinsonVLStadlerWMSokoloffMHRinker-Schaeffer CW. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary siteJ Urol200316911223310.1097/01.ju.0000051580.89109.4bSearch in Google Scholar
Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No.26. Arch Ophthalmol 2005; 123: 1639–43.Diener-WestMReynoldsSMAgugliaroDJCaldwellRCummingKEarleJDDevelopment of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No.26Arch Ophthalmol200512316394310.1001/archopht.123.12.1639Search in Google Scholar
Straatsma BR, Diener-West M, Caldwell R, Engstrom RE. Mortality after deferral of treatment or no treatment for choroidal melanoma. Am J Ophthalmol 2003; 136: 47–54.StraatsmaBRDiener-WestMCaldwellREngstromREMortality after deferral of treatment or no treatment for choroidal melanomaAm J Ophthalmol2003136475410.1016/S0002-9394(02)02270-5Search in Google Scholar
Damato B. Does ocular treatment of uveal melanoma influence survival. Br J Cancer 2010; 103: 285–90.DamatoBDoes ocular treatment of uveal melanoma influence survivalBr J Cancer20101032859010.1038/sj.bjc.6605765292001920661247Search in Google Scholar
